HIV/AIDS Testing: A Global Strategic Business Report
San Jose, California (Vocus) October 26, 2010
AIDS continues to command high priority concern in the global healthcare sector, with continuous rise witnessed in the number of people living with AIDS. However, substantial developments in the area have assisted in preventing new HIV infections and reducing the number of AIDS-related deaths. The market is significantly influenced by revolutionary changes in the field of disease monitoring and management. Advent of novel disease-progression study techniques such as genotyping and phenotyping, and developments in viral load monitoring tests have significantly improved therapies offered to HIV/AIDS infected individuals. Rapid HIV test kits are expected to drive future growth in the HIV/AIDS testing market, due to its ability to produce results in less time. Further, home testing practices are expected to become increasingly popular, allowing healthcare providers to identify more number of HIV-affected people.
Europe and the United States accounted for a major share of the revenues generated in the global HIV/AIDS Testing market, as stated by the new market research report on HIV/AIDS testing. Developing countries from Asia and Africa account for over 90% of the total global HIV population. Though HIV testing is the basis of prevention and treatment of AIDS in several such countries, lack of funds and the need for state-of-the-art equipment to run standard tests hampers widespread adoption of HIV tests. Asia-Pacific represents the fastest growing market for HIV/AIDS testing.
Demand for HIV/AIDS monitoring test is driven by the need for constant monitoring to determine disease progression. Further, rising instances of drug resistance and increasing number of genotyping tests are also fuelling demand for monitoring tests. The US and Europe account for more than three-quarters of the overall market, due partly to the affordability and accessibility of these expensive tests in the regions.
Antibody detection is the most commonly used method to detect HIV infection. Accurate HIV antibody testing is a laborious process, since positive results must be confirmed using several different tests. HIV/AIDS screening tests comprising ELISA and Rapid tests represents the largest product segment in the HIV/AIDS testing market.
The HIV testing market is highly competitive with several medical diagnostic, pharmaceutical and biotechnology companies vying for market share. Major players profiled in the report include Abbott Laboratories Inc., Biomérieux SA, Bio-Rad Laboratories Inc., Calypte Biomedical Corporation, Celera Group, Gen-Probe Inc., Innogenetics NV, MedMira Laboratories Inc., OraSure Technologies Inc., Ortho-Clinical Diagnostics Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics Inc.
The research report titled “HIV/AIDS Testing: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a strategic review of key market trends, recent product launches, strategic corporate initiatives, and profiles of key market participants. The report provides annual sales estimates and projections for HIV/AIDs Testing market for the years 2007 through 2015, and 2000 to 2006 by the following geographic markets – United States, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/HIV_AIDS_Testing_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/